Tamarack Advisers as of Dec. 31, 2018
Portfolio Holdings for Tamarack Advisers
Tamarack Advisers holds 21 positions in its portfolio as reported in the December 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Allscripts Healthcare Solutions (MDRX) | 12.0 | $29M | 3.1M | 9.64 | |
| Medtronic | 10.2 | $25M | 275k | 90.96 | |
| NuVasive | 10.1 | $25M | 500k | 49.56 | |
| Novocure Ltd call | 9.2 | $22M | 670k | 33.48 | |
| AtriCure (ATRC) | 7.5 | $18M | 600k | 30.60 | |
| NxStage Medical | 7.3 | $18M | 625k | 28.62 | |
| Stericycle (SRCL) | 6.4 | $16M | 425k | 36.69 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 6.2 | $15M | 975k | 15.65 | |
| Bio-Rad Laboratories (BIO) | 5.7 | $14M | 60k | 232.22 | |
| Rigel Pharmaceuticals | 5.2 | $13M | 5.5M | 2.30 | |
| Service Corporation International (SCI) | 4.5 | $11M | 275k | 40.26 | |
| Hologic (HOLX) | 3.4 | $8.2M | 200k | 41.10 | |
| Portola Pharmaceuticals | 3.2 | $7.8M | 400k | 19.52 | |
| McKesson Corporation (MCK) | 2.2 | $5.5M | 50k | 110.48 | |
| Correvio Pharma Corp | 2.2 | $5.3M | 2.1M | 2.49 | |
| Obalon Therapeutics | 1.8 | $4.3M | 2.1M | 2.07 | |
| Vitamin Shoppe | 1.2 | $2.8M | 600k | 4.74 | |
| Optinose (OPTN) | 0.8 | $1.9M | 300k | 6.20 | |
| Streamline Health Solutions (STRM) | 0.6 | $1.6M | 2.0M | 0.81 | |
| Ophthotech | 0.5 | $1.2M | 1.0M | 1.20 | |
| Portola Pharmaceuticals | 0.1 | $175k | 3.5k | 50.00 |
